Raphael Pharmaceutical Inc. (RAPH)

Raphael Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.05	0.02	0.23	0.29	0.15
Cash & Short-Term Investments	0.05	0.02	0.23	0.29	0.15
Cash Growth	136.84%	-91.74%	-20.14%	88.23%	61.05%
Other Receivables	0	0	0.01	0.04	0.09
Receivables	0	0	0.01	0.04	0.09
Prepaid Expenses	0	0	-	0.01	0.18
Total Current Assets	0.05	0.03	0.24	0.33	0.42
Property, Plant & Equipment	0	0	0	0	-
Total Assets	0.05	0.03	0.24	0.33	0.42
Accounts Payable	0.16	0.13	0.07	0.07	0.11
Accrued Expenses	1.29	0.6	0.06	0.16	0.19
Short-Term Debt	0.03	0.04	-	-	-
Total Current Liabilities	1.49	0.77	0.13	0.23	0.29
Total Liabilities	1.49	0.77	0.13	0.23	0.29
Common Stock	0.2	0.19	0.19	0.16	0.13
Additional Paid-In Capital	8.53	7.96	7.39	5.98	2.67
Retained Earnings	-10.17	-8.89	-7.37	-6.03	-2.67
Comprehensive Income & Other	-	-	-0.1	-	-
Shareholders' Equity	-1.43	-0.74	0.11	0.11	0.13
Total Liabilities & Equity	0.05	0.03	0.24	0.33	0.42
Total Debt	0.03	0.04	-	-	-
Net Cash (Debt)	0.01	-0.02	0.23	0.29	0.15
Net Cash Growth	-	-	-20.14%	88.23%	-
Net Cash Per Share	0.00	-0.00	0.01	0.02	0.01
Filing Date Shares Outstanding	20.18	19.63	18.66	16.14	12.97
Total Common Shares Outstanding	20.18	18.7	18.5	15.62	12.97
Working Capital	-1.44	-0.74	0.11	0.1	0.13
Book Value Per Share	-0.07	-0.04	0.01	0.01	0.01
Tangible Book Value	-1.43	-0.74	0.11	0.11	0.13
Tangible Book Value Per Share	-0.07	-0.04	0.01	0.01	0.01

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.